Walled Lake Planning & Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Walled Lake Planning & Wealth Management's NVS Position: Q2 2026 in Review
Walled Lake Planning & Wealth Management increased its Novartis (NVS) stake by 0.27% in Q2 2026, buying an estimated $20.5K and bringing the position to 50,139 shares worth $7.86M. The position accounts for 1.98% of the portfolio, ranked #15.
Walled Lake Planning & Wealth Management first reported a position in NVS in Q1 2022 and has held it in 18 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Walled Lake Planning & Wealth Management held 50,139 shares of Novartis worth $7.86M as of Q2 2026.
- Walled Lake Planning & Wealth Management bought 137 Novartis shares in Q2 2026, an estimated $20.5K.
- Novartis made up 1.98% of Walled Lake Planning & Wealth Management's portfolio in Q2 2026, its #15 holding.
- Walled Lake Planning & Wealth Management first reported a position in Novartis in Q1 2022 and has held it in 18 quarters since.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Walled Lake Planning & Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.